Guidelines for the treatment of psoriatic arthritis with biologics
Guidelines for the treatment of psoriatic arthritis with biologics
Guidelines for the treatment of psoriatic arthritis with biologics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
105 Vieira FJ, Callado MR, Vieira WP. Abatacept as an option <strong>the</strong>rapy in difficult to treat <strong>psoriatic</strong> <strong>arthritis</strong>.<br />
Rheumatology international 2010;30(6):849‐50.<br />
106 Mease P, Genovese MC, Gladstein G, et al. Abatacept in <strong>the</strong> <strong>treatment</strong> <strong>of</strong> patients <strong>with</strong> <strong>psoriatic</strong><br />
<strong>arthritis</strong>: results <strong>of</strong> a six‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II trial.<br />
Arthritis Rheum 2011;63(4):939‐48.<br />
107 Schett G, Wollenhaupt J, Papp K, et al. Apremilast is active in <strong>the</strong> <strong>treatment</strong> fo <strong>psoriatic</strong> <strong>arthritis</strong> (PsA).<br />
Arthritis Rheum 2009;60 (10):S1258 (abstract).<br />
108 Mease PJ, Wei N, Fudman EJ, et al. Safety, tolerability, and clinical outcomes after intraarticular<br />
injection <strong>of</strong> a recombinant adeno‐associated vector containing a tumor necrosis factor antagonist gene: results<br />
<strong>of</strong> a phase 1/2 Study. The Journal <strong>of</strong> rheumatology 2010;37(4):692‐703.<br />
27
Change language